Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 2
1995 2
1997 5
1998 4
1999 4
2000 15
2001 11
2002 16
2003 13
2004 9
2005 18
2006 13
2007 21
2008 21
2009 29
2010 21
2011 27
2012 20
2013 28
2014 24
2015 18
2016 19
2017 21
2018 19
2019 13
2020 21
2021 23
2022 25
2023 26
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

440 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders.
Walter HJ, Bukstein OG, Abright AR, Keable H, Ramtekkar U, Ripperger-Suhler J, Rockhill C. Walter HJ, et al. J Am Acad Child Adolesc Psychiatry. 2020 Oct;59(10):1107-1124. doi: 10.1016/j.jaac.2020.05.005. Epub 2020 May 18. J Am Acad Child Adolesc Psychiatry. 2020. PMID: 32439401
Anxiety disorders are among the most common psychiatric disorders in children and adolescents. As reviewed in this guideline, both cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitor (SSRI) medication have considerable …
Anxiety disorders are among the most common psychiatric disorders in children and adolescents. As reviewed in this guideline, both cognitive …
Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.
Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A. Strawn JR, et al. Expert Opin Pharmacother. 2018 Jul;19(10):1057-1070. doi: 10.1080/14656566.2018.1491966. Expert Opin Pharmacother. 2018. PMID: 30056792 Free PMC article. Review.
Generalized anxiety disorder (GAD) often begins during adolescence or early adulthood and persists throughout the lifespan. Randomized controlled trials support the efficacy of selective serotonin and selective serotonin norepinephrine reuptake …
Generalized anxiety disorder (GAD) often begins during adolescence or early adulthood and persists throughout the lifespan. Randomized contr …
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.
Strawn JR, Mills JA, Poweleit EA, Ramsey LB, Croarkin PE. Strawn JR, et al. Pharmacotherapy. 2023 Jul;43(7):675-690. doi: 10.1002/phar.2767. Epub 2023 Jan 27. Pharmacotherapy. 2023. PMID: 36651686 Free PMC article. Review.
INTRODUCTION: Selective serotonin reuptake inhibitors (SSRIs) and, to a lesser extent, serotonin-norepinephrine reuptake inhibitors (SNRIs) are the cornerstone of pharmacotherapy for children and adolescents with anxiety and depressive disorders …
INTRODUCTION: Selective serotonin reuptake inhibitors (SSRIs) and, to a lesser extent, serotonin-norepinephrine …
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.
Chang L, Sultan S, Lembo A, Verne GN, Smalley W, Heidelbaugh JJ. Chang L, et al. Gastroenterology. 2022 Jul;163(1):118-136. doi: 10.1053/j.gastro.2022.04.016. Gastroenterology. 2022. PMID: 35738724
The technical review panel prioritized clinical questions and outcomes according to their importance for clinicians and patients and conducted an evidence review of the following agents: tenapanor, plecanatide, linaclotide, tegaserod, lubiprostone, polyethylene glycol laxatives, …
The technical review panel prioritized clinical questions and outcomes according to their importance for clinicians and patients and conduct …
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.
Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, Christmas DM, Davies S, Fineberg N, Lidbetter N, Malizia A, McCrone P, Nabarro D, O'Neill C, Scott J, van der Wee N, Wittchen HU. Baldwin DS, et al. J Psychopharmacol. 2014 May;28(5):403-39. doi: 10.1177/0269881114525674. Epub 2014 Apr 8. J Psychopharmacol. 2014. PMID: 24713617 Free article.
The guidelines are based on available evidence, were constructed after extensive feedback from participants, and are presented as recommendations to aid clinical decision-making in primary, secondary and tertiary medical care. They may also serve as a source of information …
The guidelines are based on available evidence, were constructed after extensive feedback from participants, and are presented as recommenda …
Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Major and Persistent Depressive Disorders.
Walter HJ, Abright AR, Bukstein OG, Diamond J, Keable H, Ripperger-Suhler J, Rockhill C. Walter HJ, et al. J Am Acad Child Adolesc Psychiatry. 2023 May;62(5):479-502. doi: 10.1016/j.jaac.2022.10.001. Epub 2022 Oct 21. J Am Acad Child Adolesc Psychiatry. 2023. PMID: 36273673
OBJECTIVE: To enhance the quality of care and clinical outcomes for children and adolescents with major depressive disorder (MDD) and persistent depressive disorder (PDD). ...RESULTS: Psychotherapy (specifically, cognitive-behavioral and interpersonal therapies) and …
OBJECTIVE: To enhance the quality of care and clinical outcomes for children and adolescents with major depressive disorder (MDD) and …
Selective Inhibition of the Serotonin Transporter in the Treatment of Depression: Sertraline, Fluoxetine and Citalopram.
Szoke-Kovacs Z, More C, Szoke-Kovacs R, Mathe E, Frecska E. Szoke-Kovacs Z, et al. Neuropsychopharmacol Hung. 2020 Mar;22(1):4-15. Neuropsychopharmacol Hung. 2020. PMID: 32329748 Free article.
Discovery and development of the selective serotonin reuptake inhibitors mark a milestone in neuropharmacology. ...Hence, despite certain non-desired effects associated with selective serotonin reuptake inhibitor applications, this …
Discovery and development of the selective serotonin reuptake inhibitors mark a milestone in neuropharmacology. ...Henc …
A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
Albert U, Marazziti D, Di Salvo G, Solia F, Rosso G, Maina G. Albert U, et al. Curr Med Chem. 2018;25(41):5647-5661. doi: 10.2174/0929867325666171222163645. Curr Med Chem. 2018. PMID: 29278206
BACKGROUND: Serotonin reuptake inhibitors (SRIs) and cognitive-behavioral psychotherapy (CBT) are first-line treatments for obsessive-compulsive disorder (OCD). ...RESULTS: We identified five strategies supported by positive results in placebo-controlled randomized …
BACKGROUND: Serotonin reuptake inhibitors (SRIs) and cognitive-behavioral psychotherapy (CBT) are first-line treatments for ob …
The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.
Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. Dunkley EJ, et al. QJM. 2003 Sep;96(9):635-42. doi: 10.1093/qjmed/hcg109. QJM. 2003. PMID: 12925718
A learning dataset of 473 selective serotonin reuptake inhibitor (SSRI)-alone overdoses was used to determine individual clinical features predictive of serotonin toxicity by univariate analysis. ...DISCUSSION: These redefined criteria for se …
A learning dataset of 473 selective serotonin reuptake inhibitor (SSRI)-alone overdoses was used to determine in …
Esketamine for treatment-resistant depression.
[No authors listed] [No authors listed] Drug Ther Bull. 2020 Dec;58(12):183-188. doi: 10.1136/dtb.2020.000043. Drug Ther Bull. 2020. PMID: 33243929 Review.
Generic name: Esketamine hydrochloride Brand name: Spravato Formulation: 28mg in 0.2ml nasal spray solution Market Authorisation holder: Janssen-Cilag International NV Indication: Treatment resistant major depressive disorder in adults who have failed to respond to at least two d …
Generic name: Esketamine hydrochloride Brand name: Spravato Formulation: 28mg in 0.2ml nasal spray solution Market Authorisation holder: Jan …
440 results